What happened
Genesem disclosed a supply contract with SK hynix, worth US$4.07M, about 10.57% of its recent annual revenue, running through Sep 2026.
For context, this single contract equals about 10.57% of the company's most recent annual revenue.
| Counterparty | SK hynix |
|---|---|
| Contract value | US$4.07M |
| vs. recent revenue | 10.57% |
| Through | Sep 2026 (from Apr 2026) |
| Filed | 2026-04-15, Supply contract signed |
| Source | DART rcept 20260415900875 → open original filing |
Source: DART. Information only, not investment advice.